ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

703 hedge funds and large institutions have $22.6B invested in Alexion Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 261 increasing their positions, 262 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
703
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
18
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$275M
Puts
$315M
Net Calls
Net Calls Change

Top Buyers

1 +$324M
2 +$150M
3 +$94.5M
4
AL
AJO LP
Pennsylvania
+$91.5M
5
Nomura Holdings
Nomura Holdings
Japan
+$67.7M

Top Sellers

1 -$495M
2 -$367M
3 -$107M
4
HM
HealthCor Management
New York
-$74.8M
5
DnB Asset Management
DnB Asset Management
Norway
-$74.1M
Name Holding Trade Value Shares
Change
Change in
Stake
251
$3.47M
252
$3.44M
253
$3.42M
254
$3.32M
255
$3.32M
256
$3.25M
257
$3.23M
258
$3.13M
259
$3.06M
260
$3.02M
261
$2.98M
262
$2.96M
263
$2.88M
264
$2.87M
265
$2.83M
266
$2.81M
267
$2.7M
268
$2.68M
269
$2.66M
270
$2.62M
271
$2.61M
272
$2.6M
273
$2.59M
274
$2.56M
275
$2.56M